Breast Cancer

Cancer researchers are testing a variety of new treatments for patients with metastatic breast cancer.

A new approach to radiation treatment in early-stage breast cancer employs a larger dose on a shorter schedule.

The FDA approves Avastin for breast cancer and a lung cancer trial involving Nexavar shows no survival benefit.

Who needs treatment after breast cancer surgery?

Risk varies for BRCA carriers.

Breast cancer risk tool updated for African-Americans.

Fighting colon cancer was only part of the battle; this survivor then had to learn how, and what, to eat all over again.

News updates from the American Society of Hematology and the San Antonio Breast Cancer Symposium.

Proactive strategy has patients taking preventive steps to protect their bones during therapy.

Side effect may predict response to treatment.

Why aren't more women having breast reconstruction?

Recent drug approvals yield a new chemotherapy agent, a first for liver cancer, a safer prevention method, and good news for a drug-resistant cancer.

The number of women choosing aggressive breast cancer surgery has doubled in the past decade.

Gary Zollinger's legacy lives on through early detection research.

The timing of post-mastectomy reconstruction can be impacted by many factors.

Are breast cancer rates dropping because of the HRT decline, or are other factors at work?

A number of diagnostic, prognostic, or predictive tests can help determine the optimal course of treatment by using predictive markers from the patient’s or tumor’s genetic information.

Dana Reeve's death revealed the other face of lung cancer.

What's to blame for lung cancer in people who never smoked, and what that means for treatment and survival.

The FDA approves third kidney cancer drug and blood-clotting therapy while delaying review on a prostate cancer vaccine, and one drug edges another in a colorectal cancer clinical trial.

Updates from the 2007 meeting of the American Society of Clinical Oncology includes news on liver, kidney, lung, colon, pancreatic and breast cancers.

Patients benefit from ease and success of modern breast cancer screening.

The mainstays of screening for recurrent breast cancer remains physical exams and mammography, although researchers are looking for better ways to predict and find recurrences.

As data emerge from a surge of new therapies, doctors combine the best of the best.

Women need [and are now getting] more than medical care to heal from breast cancer.

Breast cancer prevention meets success with new agents and a new thinking.

A guide to how breast cancers are staged, from in situ (stage 0) to metastatic (stage IV).

A once frightening diagnosis, inflammatory breast cancer now has treatment options.

More coverage means more people are screened, and colon cancers are caught earlier.

Why breast cancer patients may gain weight during treatment and how to manage it.